Preserved Heart Failure Trial Misses Endpoint, But Drug May Benefit Some Patients
Sun, 01 Sep 2019 14:30:30 BST
The number of patients with heart failure with preserved ejection fraction is on the rise, and the search is on for a therapy that can improve health outcomes in this group of patients for whom no approved therapies are available.
University of Glasgow cardiovascular scientist receives AHA premier award of research excellence
Fri, 06 Sep 2019 09:43:00 BST
Professor Rhian Touyz MBBCh, PhD, FAHA, FMedSci, Director of the Institute of Cardiovascular and Medical Sciences at the University of Glasgow, is to receive the 2019 award of research excellence by the American Heart Association (AHA) Council on Hypertension
Diabetes medication can be used to treat heart failure
Sun, 01 Sep 2019 13:30:00 BST
A common diabetes medication, originally introduced as a treatment for diabetes, can be successfully used to treat patients with heart failure, reducing their risk of worsening heart failure or death from cardiovascular causes by more than 25%.